Preview

Nephrology (Saint-Petersburg)

Advanced search

DYNAMICS OF KIDNEY INJURY BIOMARKERS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION (PILOT STUDY)

Abstract

THE AIM. To evaluate dynamics of tubular damage biomarkers (BMs) and to determine frequency of acute kidney injury (AKI) according to routine diagnostics following hematopoietic stem cell transplantation (HSCT). PATIENTS AND METHODS. The study involved 30 patients after allogeneic hematopoietic stem cell transplantation (HSCT). The urine samples were taken 7 days prior to HSCT (week 0), on the weeks 1, 2, 3 and 4. BMs concentrations (calbindin, clusterin, IL-18, KIM-1, GST-п, MCP-1) were estimated. Serum creatinine was measured at the same time periods. Clinical AKI was diagnosed according to AKIN/ KDIGO (acute kidney injury network/kidney disease improving global outcomes) classification systems. RESULTS. Clinical AKI (AKIN/KDIGO) diagnostics: the proportion of AKI (AKШN/KDIGO) cases on the weeks 1 and 2 after HSCT was 7%, on the week 3 - 17%, on the week 4- 54% (p <0.05). The frequency of cases with increase of 1 and more BMs concentrations on the week 1 following HSCT was 78%, on the week 2 - 85% and thereafter on the week 3 - 90%. The proportion of cases with simultaneous elevation of 4 and more BMs after HSCT had been progressively increasing: from 6% before HSCT to 38% on the week 4 after it. By week 4 only in 6% of cases no increase in BMs concentration was found, while the cumulative proportion of cases without clinical AKI criteria (AKIN/KDIGO) was much more higher and reached 40%. The frequency of AKI (AkIN/KDIGO) development increased in relation to the number of simultaneously increased BMs. Statistically significant direct correlations were found between BMs of proximal and distal tubules, as well as between BMs simultaneously showing the damage of both proximal and distal tubule. ROC analysis showed that BMs number has sufficient sensitivity in terms of prognosis of clinical AKI (AKIN/KDIGO) development (SAUC=0,69; p=0.006). CONCLUSION. The BMs concentration increase, showing the tubular damage following HSCT, was found in majority of patients (90%) and preceded the development of clinical AKI (AKIN/KDIGO). The evaluation of BMs concentration may be used for the assessment of subclinical tubular structural damage and prognosis of AKI.

About the Authors

K. A. Smirnov
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


V. A. Dobronravov
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


B. V. Afanasiev
Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation
Russian Federation


O. V. Galkina
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


I. M. Zubina
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


E. O. Bogdanova
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


T. V. Blinova
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


I. M. Barhatov
Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation
Russian Federation


A. V. Smirnov
Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University
Russian Federation


References

1. Chertow G.M, Burdick E, Honour M. et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11): 3365-3370

2. Wang H.E, Muntner P, Chertow G.M. et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012; 35(4): 349-355

3. Uchino S, Bellomo R, Goldsmith D. et al. An assesment of the RIFLE criteria for acute kidney failure in hospitalized patients. Crit Care Med 2006; 34(7): 1913-1917

4. Mandelbaum T, Scott D.J, Lee J. et al. Outcome of critically ill patients with acute kidney injury using the Acute kidney injury network criteria. Crit Care Med 2011; 39(12): 2659-2664

5. Nin N, Lombardi R, Frutos-Vivar F et al. VENTILA Group: Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 2010; 34(2): 109-116

6. Zeng X, Mcmahon G.M, Brunelli S.M. et al. Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals. Clin J Am Soc Nephrol 2014;9(1): 12-20

7. Hahn T, Rondeau C, Shaukat A. et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 2003; 32(4): 405-410

8. Bucaloiu I.D, Kirchner H.L, Norfolk E.R. et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012;81(5): 477-485

9. Wu V.C, Huang T.M, Lai C.F. et al. Acute on chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int 2011;80(11): 1222-1230

10. Chawla L.S, Amdur R.L, Amodeo S. et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011;79(12): 1361-1369

11. Lafrance J.P, Djurdjev O, Levin A. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant 2010;25(7): 2203-2209

12. Lopes J.A, Jorge S. Acute kidney injury following HCT: incidence, risk factors and outcome. Bone Marrow transplantation 2011;46(11): 1399-1408

13. Weiss A.S, Sandmaier B.M, Storer B. et al. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006;6(1): 89-94

14. Ellis M.J, Parikh C.R, Inriq J.K. et al. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008;8(11): 2378-2390

15. Kogon A, Hingorani S. Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol 2010;30(6): 615-626

16. Bellomo R, Kellum J.A, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004;30(1): 33-37

17. Coca S.G, Parikh C.R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008;3(2): 481-490

18. Moore E, Bellomo R. Novel biomarkers of acute kidney injury: ready for clinical application? Curr Opin Crit Care 2010;16(6): 523-525

19. Nguyen M.T, Devarajan P Biomarkers for the early detection of acute kidney injury 2008;23(12): 2151-2157

20. Doi K, Yuen P.S, Eisner C. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009;20(6): 1217-1221

21. Soni S.S, Cruz D, Bobek I. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010; 42(1): 141-150

22. Ghatanatti R, Teli A, Tirkey S.S. et al. Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery. Asian Cardiovasc Thorac Ann 2014;22(2): 234-241

23. Добронравов В.А. Обзор патофизиологии острого повреждения почек. В: Смирнов А.В, Добронравов В.А, Румянцев А.Ш, Каюков И.Г. Острое повреждение почек. МИА, 2015, 3076

24. Field M, Dronovalli V, Mistry P. et al. Urinary biomarkers of acute kidney injury in diceased organ donors-kidney injury molecule-1 as an adjunct to predicting outcome. Clin Transplant 2014;28(7): 808-815

25. Han W.K, Wagener G, Zhu Y. at al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009 4(5): 873-882

26. Levi T.M, de Souza S.P, de Magalhaes J.G. et al. Comparison of the RIFLE, AKIN and KDIGO criteria to predict mortality in critically ill patients. Rev Bras Ter Intensiva 2013;25(4): 290-296


Review

For citations:


Smirnov K.A., Dobronravov V.A., Afanasiev B.V., Galkina O.V., Zubina I.M., Bogdanova E.O., Blinova T.V., Barhatov I.M., Smirnov A.V. DYNAMICS OF KIDNEY INJURY BIOMARKERS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION (PILOT STUDY). Nephrology (Saint-Petersburg). 2015;19(6):28-33. (In Russ.)

Views: 457


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)